Recombinant vaccinia virus expressing PrM and E glycoproteins of louping ill virus: induction of partial homologous and heterologous protection in mice
- 1 September 1994
- journal article
- research article
- Published by Elsevier in Research in Veterinary Science
- Vol. 57 (2) , 188-193
- https://doi.org/10.1016/0034-5288(94)90056-6
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- A Single Chain Antibody Fragment Expressed in Bacteria Neutralizes Tick-Borne FlavivirusesVirology, 1994
- Single Amino Acid Codon Changes Detected in Louping Ill Virus Antibody-Resistant Mutants with Reduced NeurovirulenceJournal of General Virology, 1993
- High-Level Expression of the Japanese Encephalitis Virus E Protein by Recombinant Vaccinia Virus and Enhancement of Its Extracellular Release by the NS3 Gene ProductVirology, 1993
- The Murray Valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of E glycoproteinVirology, 1992
- Mice immunized with a subviral particle containing the japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infectionVirology, 1992
- Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitisVirology, 1992
- Genomic sequence of the structural proteins of louping III virus: Comparative analysis with tick-borne encephalitis virusVirology, 1991
- Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infectionVirology, 1991
- Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques.Molecular and Cellular Biology, 1985
- Linker Tailing: Unphosphorylated Linker Oligonucleotides for Joining DNA TerminiDNA, 1984